New blood test offers potential for faster, targeted treatment of non-small-cell lung cancer
Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select the best treatment option. Potential NSCLC patients usually undergo invasive tissue biopsy, which may ...
Apr 19, 2017
0
41